134 related articles for article (PubMed ID: 22079741)
21. Exocrine-endocrine pancreatic cancer and alpha-fetoprotein.
Brandi G; Nobili E; Capizzi E; Corti B; Di Cicilia R; Di Marco M; Biasco G
Pancreas; 2008 Aug; 37(2):223-5. PubMed ID: 18665089
[No Abstract] [Full Text] [Related]
22. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.
Kong D; Nishino N; Shibusawa M; Kusano M
Tissue Cell; 2007 Aug; 39(4):217-23. PubMed ID: 17560620
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
Egberts JH; Cloosters V; Noack A; Schniewind B; Thon L; Klose S; Kettler B; von Forstner C; Kneitz C; Tepel J; Adam D; Wajant H; Kalthoff H; Trauzold A
Cancer Res; 2008 Mar; 68(5):1443-50. PubMed ID: 18316608
[TBL] [Abstract][Full Text] [Related]
24. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
Deharvengt S; Wack S; Aprahamian M; Hajri A
J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
[TBL] [Abstract][Full Text] [Related]
26. Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer.
Shao Q; Liu F; Chung C; Elahi-Gedwillo K; Provenzano PP; Forsyth B; Bischof JC
Ann Biomed Eng; 2018 Jan; 46(1):25-36. PubMed ID: 28983745
[TBL] [Abstract][Full Text] [Related]
27. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma.
Stoecklein NH; Luebke AM; Erbersdobler A; Knoefel WT; Schraut W; Verde PE; Stern F; Scheunemann P; Peiper M; Eisenberger CF; Izbicki JR; Klein CA; Hosch SB
J Clin Oncol; 2004 Dec; 22(23):4737-45. PubMed ID: 15570074
[TBL] [Abstract][Full Text] [Related]
28. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer.
Zhao J; Wen X; Tian L; Li T; Xu C; Wen X; Melancon MP; Gupta S; Shen B; Peng W; Li C
Nat Commun; 2019 Feb; 10(1):899. PubMed ID: 30796212
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
31. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
[TBL] [Abstract][Full Text] [Related]
32. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.
Nagaraj S; Ziske C; Strehl J; Messmer D; Sauerbruch T; Schmidt-Wolf IG
Int Immunol; 2006 Aug; 18(8):1279-83. PubMed ID: 16772371
[TBL] [Abstract][Full Text] [Related]
34. Irreversible electroporation: an in vivo study with dorsal skin fold chamber.
Qin Z; Jiang J; Long G; Lindgren B; Bischof JC
Ann Biomed Eng; 2013 Mar; 41(3):619-29. PubMed ID: 23180025
[TBL] [Abstract][Full Text] [Related]
35. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma.
Woeste MR; Shrestha R; Geller AE; Li S; Montoya-Durango D; Ding C; Hu X; Li H; Puckett A; Mitchell RA; Hayat T; Tan M; Li Y; McMasters KM; Martin RCG; Yan J
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072351
[TBL] [Abstract][Full Text] [Related]
36. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma.
Kotopoulis S; Stigen E; Popa M; Safont MM; Healey A; Kvåle S; Sontum P; Gjertsen BT; Gilja OH; McCormack E
J Control Release; 2017 Jan; 245():70-80. PubMed ID: 27871988
[TBL] [Abstract][Full Text] [Related]
37. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
[TBL] [Abstract][Full Text] [Related]
38. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects.
Bower M; Sherwood L; Li Y; Martin R
J Surg Oncol; 2011 Jul; 104(1):22-8. PubMed ID: 21360714
[TBL] [Abstract][Full Text] [Related]
39. New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study.
Rudno-Rudzińska J; Kielan W; Guziński M; Płochocki M; Antończyk A; Kulbacka J
Surg Oncol; 2021 Sep; 38():101634. PubMed ID: 34303953
[TBL] [Abstract][Full Text] [Related]
40. Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.
Bayer C; Liebhardt ME; Schmid TE; Trajkovic-Arsic M; Hube K; Specht HM; Schilling D; Gehrmann M; Stangl S; Siveke JT; Wilkens JJ; Multhoff G
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):694-700. PubMed ID: 24521683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
